Application value of blood metagenomic next-generation sequencing in patients with connective tissue diseases.

MLA

Su, Rui, et al. “Application Value of Blood Metagenomic Next-Generation Sequencing in Patients with Connective Tissue Diseases.” Frontiers in Immunology, vol. 13, Aug. 2022, p. 939057. EBSCOhost, https://doi.org/10.3389/fimmu.2022.939057.

APA

Su, R., Yan, H., Li, N., Ding, T., Li, B., Xie, Y., Gao, C., Li, X., & Wang, C. (2022). Application value of blood metagenomic next-generation sequencing in patients with connective tissue diseases. Frontiers in Immunology, 13, 939057. https://doi.org/10.3389/fimmu.2022.939057

Chicago

Su, Rui, Huanhuan Yan, Na Li, Tingting Ding, Baochen Li, Yuhuan Xie, Chong Gao, Xiaofeng Li, and Caihong Wang. 2022. “Application Value of Blood Metagenomic Next-Generation Sequencing in Patients with Connective Tissue Diseases.” Frontiers in Immunology 13 (August): 939057. doi:10.3389/fimmu.2022.939057.